Sign In
Buy PRT
$2.28
-0.0200 (-0.87%)
At Close: Jun 23, 2026
PermRock Royalty Trust Declares Monthly Cash Distribution
06:30am, Thursday, 18'th Jun 2026
DALLAS, June 18, 2026 /PRNewswire/ -- PermRock Royalty Trust (NYSE:PRT) (the "Trust") today declared a monthly cash distribution to record holders of its trust units representing beneficial interests
PermRock Royalty Trust Declares Monthly Cash Distribution
06:30am, Monday, 18'th May 2026
DALLAS, May 18, 2026 /PRNewswire/ -- PermRock Royalty Trust (NYSE:PRT) (the "Trust") today declared a monthly cash distribution to record holders of its trust units representing beneficial interests i
The structural problem no oil price recovery can fix for PRT investors
11:04am, Monday, 04'th May 2026
The headline thesis sounds airtight: West Texas Intermediate crude pushed back toward $100 a barrel in late April, even briefly touching almost $115 on April 7.
PermRock Royalty Trust Declares Monthly Cash Distribution
06:30am, Monday, 20'th Apr 2026
DALLAS, Texas, April 20, 2026 /PRNewswire/ -- PermRock Royalty Trust (NYSE: PRT) (the "Trust") today declared a monthly cash distribution to record holders of its trust units representing beneficial i
Data Demonstrate Potential for Differentiated Efficacy and Safety Profile, Including Complete Responses as Monotherapy in Multiple CDX and PDX Models of HR+/HER2- Breast Cancer
PermRock Royalty Trust Declares Monthly Cash Distribution
06:30am, Friday, 20'th Mar 2026
DALLAS, March 20, 2026 /PRNewswire/ -- PermRock Royalty Trust (NYSE: PRT) (the "Trust") today declared a monthly cash distribution to record holders of its trust units representing beneficial interest
WILMINGTON, Del., March 17, 2026 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a precision oncology company, today announced that a poster with preclinical data on the Company'
Prelude Therapeutics Reports Full Year 2025 Financial Results and Provides Program Outlook for 2026
07:01am, Tuesday, 10'th Mar 2026
Received FDA clearance of Investigational New Drug application (IND) for PRT12396, mutant-selective JAK2V617F inhibitor in the first quarter of 2026 Phase 1 study of PRT12396 in patients with polycyth
PermRock Royalty Trust Declares Monthly Cash Distribution
06:30am, Tuesday, 17'th Feb 2026
DALLAS, Feb. 17, 2026 /PRNewswire/ -- PermRock Royalty Trust (NYSE:PRT) (the "Trust") today declared a monthly cash distribution to record holders of its trust units representing beneficial interests
These $5 Stocks and ETFs Are Paying Huge Yields to 12%, but There's a Catch
07:40am, Thursday, 05'th Feb 2026
While most of Wall Street focuses on large- and mega-cap stocks, which offer safety and liquidity, many investors are constrained in the number of shares they can buy.
WILMINGTON, Del., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a precision oncology company, today announced that the U.S. Food and Drug Administration (FDA) cle
PermRock Royalty Trust Declares Monthly Cash Distribution
06:30am, Tuesday, 20'th Jan 2026
DALLAS, Jan. 20, 2026 /PRNewswire/ -- PermRock Royalty Trust (NYSE: PRT) (the "Trust") today declared a monthly cash distribution to record holders of its trust units representing beneficial interests
LARGE CAP INTERNATIONAL PORTFOLIO Buys 594 Shares of Brookfield Wealth Solutions Ltd (BNT)
04:38pm, Monday, 19'th Jan 2026
Summary LARGE CAP INTERNATIONAL PORTFOLIO initiated a new position in Brookfield Wealth Solutions Ltd(BNT), purchasing 594 shares valued at approximate
PermRock Royalty Trust Declares Monthly Cash Distribution
06:30am, Friday, 19'th Dec 2025
DALLAS , Dec. 19, 2025 /PRNewswire/ -- PermRock Royalty Trust (NYSE: PRT) (the "Trust") today declared a monthly cash distribution to record holders of its trust units representing beneficial interes
PermRock Royalty Trust Declares Monthly Cash Distribution
10:07am, Monday, 17'th Nov 2025
DALLAS , Nov. 17, 2025 /PRNewswire/ -- PermRock Royalty Trust (NYSE:PRT) (the "Trust") today declared a monthly cash distribution to record holders of its trust units representing beneficial interests
